Literature DB >> 32667497

Hypothermia treatment reduced cyclin-dependent kinase 5-mediated inflammation in ischemic stroke and improved outcomes in ischemic stroke patients.

Sombat Muengtaweepongsa1, Winchana Srivilaithon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32667497      PMCID： PMC7337214          DOI： 10.6061/clinics/2020/e1992

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN： 1807-5932            Impact factor:   2.365


× No keyword cloud information.
  5 in total

Review 1.  What is the proper target temperature for out-of-hospital cardiac arrest?

Authors:  Maria Vargas; Yuda Sutherasan; Giuseppe Servillo; Paolo Pelosi
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2015-09-30

2.  Tympanic temperature measurements: are they reliable in the critically ill? A clinical study of measures of agreement.

Authors:  John L Moran; John Victor Peter; Patricia J Solomon; Bernadette Grealy; Tania Smith; Wendy Ashforth; Megan Wake; Sandra L Peake; Aaron R Peisach
Journal:  Crit Care Med       Date:  2007-01       Impact factor: 7.598

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial.

Authors:  Odette A Harris; Carrie R Muh; Monique C Surles; Yi Pan; Grace Rozycki; Jana Macleod; Kirk Easley
Journal:  J Neurosurg       Date:  2009-06       Impact factor: 5.115

5.  Hypothermia treatment ameliorated cyclin-dependent kinase 5-mediated inflammation in ischemic stroke and improved outcomes in ischemic stroke patients.

Authors:  Hongwei Sun; Juan Cai; Shiqi Shen; Xiaohui Ren
Journal:  Clinics (Sao Paulo)       Date:  2019-10-21       Impact factor: 2.365
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.